Each institution is putting up $75 million for the five year effort, called the Strategic Research Initiative.
The research will focus on cancer, heart disease and neuroscience.
“The endpoint is really to develop personalized medicine and to take model discoveries out of our laboratories and into the clinic,” said Dr. David Wilkes (above), executive associate dean for research affairs at the medical school.
Wilkes says there will be particular emphasis on the genetics of cardiovascular disease, neurological conditions such as Alzheimer’s and autism and the development of new cancer drugs.
Wilkes says the initiative also will allow the two entities to attract new high level researchers and more grant money.
(Photo courtesy of IU School of Medicine)